Total Payments
$30,478
2024 Payments
$2,967
Companies
39
Transactions
373
Medicare Patients
1,632
Medicare Billing
$212,893
Payment Breakdown by Category
Research$15,315 (50.2%)
Food & Beverage$9,777 (32.1%)
Travel$5,220 (17.1%)
Education$142.94 (0.5%)
Consulting$23.88 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,315 | 19 | 50.2% |
| Food and Beverage | $9,777 | 336 | 32.1% |
| Travel and Lodging | $5,220 | 12 | 17.1% |
| Education | $142.94 | 5 | 0.5% |
| Consulting Fee | $23.88 | 1 | 0.1% |
Payments by Type
Research
$15,315
19 transactions
General
$15,164
354 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc. | $12,982 | 6 | $0 (2017) |
| Chiesi USA, Inc. | $1,982 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,799 | 45 | $0 (2024) |
| Roche Products Limited | $1,694 | 3 | $0 (2017) |
| GlaxoSmithKline, LLC. | $1,669 | 42 | $0 (2024) |
| AstraZeneca UK Limited | $1,606 | 12 | $0 (2024) |
| SANOFI US SERVICES INC. | $1,514 | 7 | $0 (2024) |
| GENZYME CORPORATION | $892.84 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $878.03 | 7 | $0 (2019) |
| ALK-Abello, Inc | $789.35 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,967 | 55 | SANOFI US SERVICES INC. ($1,514) |
| 2023 | $3,428 | 46 | Chiesi USA, Inc. ($1,982) |
| 2022 | $1,127 | 40 | AstraZeneca Pharmaceuticals LP ($254.24) |
| 2021 | $1,154 | 56 | AstraZeneca Pharmaceuticals LP ($338.51) |
| 2020 | $558.19 | 25 | Regeneron Healthcare Solutions, Inc. ($90.20) |
| 2019 | $3,788 | 73 | AstraZeneca UK Limited ($1,514) |
| 2018 | $1,747 | 35 | GlaxoSmithKline, LLC. ($835.98) |
| 2017 | $15,710 | 43 | Glenmark Pharmaceuticals Inc. ($12,982) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: BIOLOGIC | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Immunology and Neurology | ||||||
| 11/21/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Immunology | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $34.98 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.91 | General |
| 10/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Immunology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 10/09/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | — | Education | In-kind items and services | $57.00 | General |
| 09/05/2024 | Greer Laboratories, Inc. | ORALAIR (Biological) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Allergy Treatment | ||||||
| 08/28/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Immunology | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Respiratory | ||||||
| 07/24/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Immunology | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.89 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Inflammation | ||||||
| 07/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $12,982 | 6 |
| A Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose Ranging Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous SAR443765 in Adult Participants With Moderate to Severe Asthma | SANOFI US SERVICES INC. | $1,514 | 7 |
| A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, MULTICENTER, STRATIFIED ST | GlaxoSmithKline, LLC. | $818.32 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 457 | 4,184 | $138,681 | $59,551 |
| 2022 | 6 | 413 | 3,984 | $161,689 | $54,260 |
| 2021 | 8 | 357 | 3,412 | $110,527 | $48,034 |
| 2020 | 8 | 405 | 4,216 | $115,067 | $51,048 |
Total Patients
1,632
Total Services
15,796
Medicare Billing
$212,893
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 166 | 251 | $47,420 | $20,107 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 90 | $19,355 | $12,111 | 62.6% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 32 | 919 | $20,680 | $9,781 | 47.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 42 | 2,214 | $25,910 | $6,530 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $10,007 | $5,793 | 57.9% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 26 | 389 | $6,931 | $2,274 | 32.8% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 12 | 189 | $3,867 | $1,493 | 38.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 53 | 80 | $4,511 | $1,463 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 308 | $61,600 | $25,940 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 81 | 81 | $14,985 | $9,140 | 61.0% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 26 | 727 | $18,175 | $8,149 | 44.8% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 47 | 2,337 | $51,414 | $6,864 | 13.4% |
| 95115 | Professional service for single injection of allergen | Office | 2022 | 29 | 475 | $11,875 | $3,055 | 25.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 42 | 56 | $3,640 | $1,113 | 30.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 256 | $41,550 | $22,203 | 53.4% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 27 | 794 | $14,390 | $9,082 | 63.1% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 34 | 1,757 | $29,042 | $5,422 | 18.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $8,140 | $4,973 | 61.1% |
| 95115 | Injection of incremental dosages of allergen | Office | 2021 | 26 | 380 | $8,225 | $2,464 | 30.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 13 | $2,900 | $1,837 | 63.3% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 40 | 60 | $3,460 | $1,262 | 36.5% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 12 | 108 | $2,820 | $791.70 | 28.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 170 | 267 | $40,050 | $19,495 | 48.7% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 31 | 1,031 | $15,465 | $10,951 | 70.8% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 43 | 2,181 | $28,657 | $6,847 | 23.9% |
About Dr. David Fuentes, MD
Dr. David Fuentes, MD is a Allergy healthcare provider based in Boerne, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013911544.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Fuentes, MD has received a total of $30,478 in payments from pharmaceutical and medical device companies, with $2,967 received in 2024. These payments were reported across 373 transactions from 39 companies. The most common payment nature is "" ($15,315).
As a Medicare-enrolled provider, Fuentes has provided services to 1,632 Medicare beneficiaries, totaling 15,796 services with total Medicare billing of $212,893. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy
- Location Boerne, TX
- Active Since 06/13/2005
- Last Updated 09/29/2025
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1013911544
Products in Payments
- Xolair (Biological) $1,944
- DUPIXENT (Biological) $1,598
- FASENRA (Biological) $845.39
- Haegarda (Biological) $463.73
- Dust mite (D. farinae) (Biological) $454.32
- TEZSPIRE (Biological) $337.15
- Odactra (Drug) $293.58
- DUPIXENT (Drug) $274.79
- TRELEGY ELLIPTA (Drug) $273.34
- FASENRA (Drug) $255.73
- Hizentra (Biological) $213.72
- Xhance (Drug) $213.38
- NUCALA (Biological) $207.59
- ATOPIC DERMATITIS - DISEASE (Drug) $182.94
- AIRSUPRA (Drug) $175.47
- AREXVY (Drug) $174.55
- RUCONEST (Biological) $159.39
- FEVIPIPRANT (Drug) $159.35
- Orladeyo (Drug) $147.38
- CUVITRU (Biological) $146.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.